Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Neurovascular Market Tilts Toward A Tipping Point

This article was originally published in Start Up

Executive Summary

Acute ischemic stroke used to be a device category that promised a slow but certain death for start-ups. But there's lots of life in the market, as evidenced by a recent wave of consolidation. Meanwhile, hemorrhagic stroke companies have been perfecting the treatment of cerebral aneurysms.
Advertisement

Related Content

Neurointerventional Device Update: The Burgeoning Stroke Toolbox
Neurointerventional Device Update: The Burgeoning Stroke Toolbox
Device/Diagnostics Quarterly Deal Statistics, Q1 2012
Stroke Devices: Innovation Drives Growth
Stroke Devices: Innovation Drives Growth
Is Therapeutic Hypothermia Finally Heating Up?
Device-Based Stroke Intervention: An Interview with Adnan Siddiqui
Concentric Medical: Breaking the Stroke Device Barrier

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC092194

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel